Influenza A (H1N1) 2009 Monovalent Vaccine and Leustatin injection
Determining the interaction of Influenza A (H1N1) 2009 Monovalent Vaccine and Leustatin injection and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:If you are currently being treated or have recently been treated with cladribine, you should let your doctor know before receiving influenza virus vaccine, H1N1, inactivated. Depending on the dose and length of time you have been on cladribine, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of cladribine therapy. If you have recently been vaccinated with influenza virus vaccine, H1N1, inactivated, your doctor may choose to postpone treatment with cladribine for a couple of weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The administration of inactivated, killed, or otherwise noninfectious vaccines to immunosuppressed patients is generally safe but may be associated with a diminished or suboptimal immunologic response due to antibody inhibition. Such patients may include those who have recently received or are receiving immunosuppressive agents, antilymphocyte globulins, alkylating agents, antimetabolites, radiation, some antirheumatic agents, high dosages of corticosteroids or adrenocorticotropic agents (e.g., greater than 10 mg/day or 1 mg/kg/day of prednisone or equivalent for more than 2 weeks), or long-term topical or inhaled corticosteroids.
MANAGEMENT: In general, the US Department of Public Health Advisory Committee on Immunization Practices (ACIP) recommends that inactivated or killed vaccines be administered to non-HIV immunosuppressed patients according to the same guidelines as for healthy patients. However, higher dosages, more frequent boosters, and/or serological testing may be required in some cases. Local guidelines should be consulted. For Haemophilus influenzae b vaccine, some experts recommend that it be administered at least 2 weeks before starting or 3 months after discontinuing chemotherapy when used in patients with Hodgkin's disease. For rabies vaccine, some authorities agree that immunosuppressive agents should generally be avoided during postexposure therapy except when absolutely necessary for the treatment of other conditions. Vaccines may generally be administered to patients receiving corticosteroids as replacement therapy (e.g., for Addison's disease).
- "Product Information. Imovax Rabies (rabies vaccine)." sanofi pasteur, Swiftwater, PA.
- "Product Information. Omnihib (haemophilus b conjugate vaccine)." SmithKline Beecham, Philadelphia, PA.
- Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/655225/Greenbook_chap" ([2017 Aug]):
- Cerner Multum, Inc. "Australian Product Information." O 0
- CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18
- "Product Information. Havrix (hepatitis A vaccine)." SmithKline Beecham, Philadelphia, PA.
- "Product Information. Biothrax (anthrax vaccine adsorbed)." Emergent BioSolutions Inc., Lansing, MI.
- "Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated)." GlaxoSmithKline, Research Triangle Park, NC.
- "Product Information. Fluzone Influenza Vaccine (influenza virus vaccine)." Connaught, Swiftwater, PA.
- CDC Centers for Disease Control and Prevention "General Best Practice Guidelines for Immunization: Altered Immunocompetence. Available from: URL: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.pdf." ([2017, Apr 17]):
Generic Name: influenza virus vaccine, h1n1, inactivated
Brand name:
Synonyms: Influenza A Vaccine
Generic Name: cladribine
Brand name: Leustatin, Mavenclad
Synonyms: Leustatin (injection), Leustatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Influenza A (H1N1) 2009 Monovalent Vaccine-Leva Set
- Influenza A (H1N1) 2009 Monovalent Vaccine-Levacet
- Influenza A (H1N1) 2009 Monovalent Vaccine-Levalbuterol
- Influenza A (H1N1) 2009 Monovalent Vaccine-Levalbuterol HFA Aerosol
- Influenza A (H1N1) 2009 Monovalent Vaccine-Levalbuterol inhalation
- Influenza A (H1N1) 2009 Monovalent Vaccine-Levalbuterol Inhalation Aerosol
- Leustatin injection-Influenza A H1N1 Intranasal
- Leustatin injection-Influenza A Vaccine
- Leustatin injection-Influenza A Virus Vaccine (H5N1)
- Leustatin injection-Influenza a virus vaccine, h1n1, inactivated Intramuscular
- Leustatin injection-Influenza H1N1 Vaccine
- Leustatin injection-Influenza Vaccine Live Intranasal